Anti-IFNalpha [AIFN]
AB00792-10.0-BT
ApplicationsNeutralisation/Blocking
Product group Antibodies
TargetIFNA1
Overview
- SupplierAbsolute Antibody
- Product NameAnti-IFNalpha [AIFN]
- Delivery Days Customer9
- Application Supplier NoteAIFNalpha1bIgG01, the IgG1 version of the antibody, is able to cause downregulation of ISG15 and IFIT-1 expression ex vivo in PBMCs, induced by either recombinant IFNalpha1b or naiive IFNalpha from SLE patients sera. The antibody also reduces the total serum IgG and IgM antibody levels in a pristane-primed lupus-like mouse model. This neutralization occurs by out-competing IFNR2 for IFNalpha1b, which prevents the formation of the IFNAR2-IFNalpha interaction and the IFNalpha-mediated signaling pathway.
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDAIFN
- Gene ID3439
- Target nameIFNA1
- Target descriptioninterferon alpha 1
- Target synonymsIFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@, leIF D, interferon alpha-1, IFN-alpha-1/13, interferon alpha 1b, interferon alpha-1/13, interferon alpha-D, interferon-alpha1
- HostHuman
- IsotypeIgG1
- Protein IDP01562
- Protein NameInterferon alpha-1/13
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203




